Ultimo aggiornamento :
Stabilità e compatibilità dei farmaci
Benvenuti su Stabilis. Se desiderate ricevere la nostra newsletter trimestrale vi preghiamo di indicare il vostro indirizzo e-mail.

Per qualsiasi domanda o osservazione, contattare : infostab@stabilis.org
Banche di dati  
Bibliografia : 2178
Molecola : 786
Classe farmacologica : 42
Stabilità delle soluzioni : 4835
Stabilità come miscela : 1035
Incompatibilità : 2975
Nome commerciale : 1993
Notizie - Molecola  
Anticoagulante Soluzione orale Apixaban 21/11/2017
Antiemetico Iniezione Azasetron 09/09/2017
Antiemetico Iniezione Ramosetron 09/09/2017
Antiemetico Iniezione Dolasetron 09/09/2017
Antinfiammatorio Soluzione orale Budesonide 29/08/2017
Vitamina Soluzione orale Riboflavine 26/08/2017
Antiepilettico Soluzione orale Pregabaline 26/08/2017
Antibiotico Soluzione orale Nitrofurantoin 26/08/2017
Altro Soluzione orale Glutamine 26/08/2017
Antimuscarinico Soluzione orale Atropine sulfate 26/08/2017
Diuretico Soluzione orale Acetazolamide 26/08/2017
 antispasmodico Soluzione orale Mebeverine hydrochloride 26/08/2017
Antiepilettico Soluzione orale Topiramate 26/08/2017
Anestetico locale Collutorio Lidocaine 26/08/2017
Immunosoppressore Unguenti Sirolimus 26/08/2017
Ipolipemizzante Soluzione orale Atorvastatine 24/08/2017
Immunosoppressore Collirio Tacrolimus 23/08/2017
Vasodilatatore Iniezione Dipyridamol 10/06/2017
Antiepilettico Unguenti Gabapentine 06/06/2017
Antidepressivo Unguenti Amitriptyline 06/06/2017
Notizie - Bibliografia  
Data di entrata
4030 Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt. Int J Pharm Compound 25/10/2017
4023 Compounded Apixaban Suspensions for Enteral Feeding Tubes. Hosp Pharm 20/10/2017
4016 Extended stability of the rituximab biosimilar CT-P10 in its opened vials and after dilution and storage in polyolefin bag. Ann Pharm Fr 25/09/2017
4007 Etude de la stabilité de la vancomycine à 40 mg/ml au cours d'une perfusion de 24 heures. Hopipharm Congress 2017-Nancy 11/08/2017
4008 Formulation et étude de stabilité de crèmes au sirolimus dosées à 0,1, à 0,25 ou à 0,5% m/m. Hopipharm Congress 2017-Nancy 11/08/2017
4003 Evaluation of the physicochemical and biological stability of reconstituted and diluted SB2 (infliximab). EJHP 31/07/2017
3999 Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4. Int J Pharm Compound 28/07/2017
4001 Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox). Int J Pharm Compound 28/07/2017
3996 Updated Stability Data of Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSprend SF and Minoxidil in Espumil. Int J Pharm Compound 28/06/2017
3994 Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions. Int J Pharm Compound 22/06/2017
3992 Formulation and charaterization of 0,1% rapamycin cream for the treatment of Tuberous Sclerosis Complex-related angiofibromas. Int J Pharm 01/06/2017
3988 Stability of tacrolimus ophthalmic solution. Am J Health-Syst Pharm 19/05/2017
3984 Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water. Hosp Pharm 16/05/2017
3985 Compatibilité physique entre médicaments injectables et nutrition parentérale pédiatrique : évaluation in-vitro. Hopipharm Congress 2017 - Nancy 16/05/2017
3978 Beyond-use dating of lidocaine alone and in two “magic mouthwash” preparations. Am J Health-Syst Pharm 06/05/2017
3980 Stability study of methotrexate in 0.9% sodium chloride injection and 5% dextrose injection with limit tests for impurities. Am J Health-Syst Pharm 06/05/2017
3981 Compatibility of dexamethasone sodium phosphate with 5-HT3 receptor antagonists in infusion solutions: a comprehensive study EJHP 06/05/2017
3983 Compounding and stability evaluation of atorvastatin extemporaneous oral suspension using tablets or pure powder. EJHP 06/05/2017
3977 Stability of Melphalan in 0,9% Sodium Chloride Solutions Prepared in Polyvinyl Chloride Bags for Intravenous Injection. Drugs R D 28/04/2017
3974 Stability of frozen 1% voriconazole eye drops in glass and in innovative containers. EAHP congress - Cannes 18/04/2017
3975 Stability of 50 and 100µg/0,1mL intraocular solutions of voriconazole at 2-8°C. EAHP congress - Cannes 18/04/2017
3976 Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration. Am J Health-Syst Pharm 18/04/2017
3971 Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs. Int J Pharm Compound 10/04/2017
3969 Solubility and stability of Baclofen 3 mg/mL intrathecal formulation and its compatibility with implantable programmable intrathecal infusion systems. Neuromodulation 07/04/2017
3967 Physical compatibility of total parenteral nutrition and drugs in Y-site administration to children from neonates to adolescents. J Pharm Pharmacol 06/04/2017
3961 Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers. Int J Pharm Compound 03/04/2017
3963 Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions. Int J Pharm Compound 03/04/2017
3964 Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments. Pharmactuel 03/04/2017
3951 Antibiotic lock: In vitro stability of vancomycin and four percent sodium citrate stored in dialysis catheters at 37°C Hemodial Int 14/03/2017
3952 Antibiotic lock: In vitro stability of gentamicin and sodium citrate stored in dialysis catheters at 37°C. Hemodial Int 14/03/2017

Temps de calcul serveur : 129 millisecondes